PPIDT00302
Drug Information
| Name | Bremelanotide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB11653 |
| Type | biotech |
| Indication | Bremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of a medication or drug.[L9635] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection | Subcutaneous |
1.75 mg/0.3mL
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | Q01726 | MC1R | Melanocyte-stimulating hormone receptor | Homo sapiens | agonist | Link |
| target | P32245 | MC4R | Melanocortin receptor 4 | Homo sapiens | agonist | Link |
| target | P41968 | MC3R | Melanocortin receptor 3 | Homo sapiens | agonist | Link |
| target | P33032 | MC5R | Melanocortin receptor 5 | Homo sapiens | agonist | Link |
| target | Q01718 | MC2R | Adrenocorticotropic hormone receptor | Homo sapiens | agonist | Link |